KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Date Action Amount Person Type
Apr 21, 2024 Sell 381 Erickson Anne Common Stock
Mar 21, 2024 Buy 0 Erickson Anne Common Stock
Mar 21, 2024 Buy 2 000 Erickson Anne Stock Option (Right to Buy)
Mar 21, 2024 Buy 25 000 Erickson Anne Stock Option (Right to Buy)
Mar 21, 2024 Buy 75 000 Erickson Anne Stock Option (Right to Buy)
Mar 21, 2024 Buy 50 000 Erickson Anne Stock Option (Right to Buy)
Mar 21, 2024 Buy 50 000 Erickson Anne Stock Option (Right to Buy)
Mar 21, 2024 Buy 40 000 Erickson Anne Stock Option (Right to Buy)
Mar 21, 2024 Buy 150 000 Erickson Anne Stock Option (Right to Buy)
Mar 21, 2024 Buy 20 000 Erickson Anne Stock Option (Right to Buy)
Dec 28, 2023 Sell 84 000 Pauls Matthew Common Stock
Dec 28, 2023 Sell 19 000 Pauls Matthew Common Stock
Dec 28, 2023 Sell 10 000 Lowrance David L Common Stock
Dec 28, 2023 Buy 40 000 Elam Nevan C Common Stock
Dec 28, 2023 Buy 12 000 Elam Nevan C Common Stock
Dec 28, 2023 Buy 1 758 Elam Nevan C Common Stock
Dec 28, 2023 Sell 93 843 Elam Nevan C Common Stock
Dec 28, 2023 Sell 1 758 Elam Nevan C Stock Option (Right to Buy)
Dec 28, 2023 Sell 12 000 Elam Nevan C Stock Option (Right to Buy)
Dec 28, 2023 Sell 40 000 Elam Nevan C Stock Option (Right to Buy)
Dec 15, 2023 Sell 20 000 Lowrance David L Common Stock
Dec 14, 2023 Buy 150 000 Pratt Raymond Dennis Common Stock
Dec 14, 2023 Buy 40 000 Pratt Raymond Dennis Stock Option (Right to Buy)
Dec 14, 2023 Buy 22 500 Sun Ricky Common Stock
Dec 14, 2023 Buy 160 000 Lowrance David L Common Stock
Dec 14, 2023 Sell 30 438 Lowrance David L Common Stock
Dec 14, 2023 Buy 40 000 Lowrance David L Stock Option (Right to Buy)
Dec 14, 2023 Buy 160 000 Lutz Robert Matthew Common Stock
Dec 14, 2023 Buy 40 000 Lutz Robert Matthew Stock Option (Right to Buy)
Dec 14, 2023 Buy 450 000 Pauls Matthew Common Stock
Dec 14, 2023 Sell 109 680 Pauls Matthew Common Stock
Dec 14, 2023 Buy 225 000 Pauls Matthew Stock Option (Right to Buy)
Dec 14, 2023 Buy 22 500 Ramsay David A Common Stock
Dec 14, 2023 Buy 22 500 Van Es-johansson An Common Stock
Dec 14, 2023 Buy 22 500 Hawkins Richard J Common Stock
Dec 14, 2023 Buy 22 500 Elam Nevan C Common Stock
Dec 14, 2023 Buy 22 500 Mccracken Joseph S Common Stock
Dec 11, 2023 Buy 10 841 Hawkins Richard J Common Stock
Dec 11, 2023 Sell 10 841 Hawkins Richard J Stock Option (Right to Buy)
Dec 11, 2023 Buy 10 841 Elam Nevan C Common Stock
Dec 11, 2023 Sell 10 841 Elam Nevan C Stock Option (Right to Buy)
Jul 17, 2023 Buy 333 333 Yang Rick Common Stock
Jul 17, 2023 Buy 333 333 Walker Paul Edward Common Stock
Jul 17, 2023 Buy 333 333 Sandell Scott D Common Stock
Jul 17, 2023 Buy 333 333 Mathers Edward T Common Stock
Jul 17, 2023 Buy 333 333 Makhzoumi Mohamad Common Stock
Jul 17, 2023 Buy 333 333 Florence Anthony A. Jr. Common Stock
Jul 17, 2023 Buy 333 333 Chang Carmen Common Stock
Jul 17, 2023 Buy 333 333 Behbahani Ali Common Stock
Jul 17, 2023 Buy 333 333 Baskett Forest Common Stock
Jul 17, 2023 Buy 333 333 Growth Equity Opportunities 17, Llc Common Stock
Jun 26, 2023 Buy 6 500 Pratt Raymond Dennis Common Stock
May 26, 2023 Buy 37 124 Ramsay David A Common Stock
May 25, 2023 Buy 12 876 Ramsay David A Common Stock
May 24, 2023 Buy 50 000 Ramsay David A Common Stock
Feb 24, 2023 Buy 350 000 Lutz Robert Matthew Stock Option (Right to Buy)
Feb 24, 2023 Buy 140 000 Lutz Robert Matthew Common Stock
Feb 13, 2023 Buy 0 Lutz Robert Matthew
Dec 30, 2022 Buy 29 000 Ramsay David A Common Stock
Dec 29, 2022 Buy 7 000 Ramsay David A Common Stock
Dec 28, 2022 Buy 3 293 Ramsay David A Common Stock
Dec 23, 2022 Buy 15 707 Ramsay David A Common Stock
Dec 22, 2022 Buy 3 500 Pratt Raymond Dennis Common Stock
Dec 22, 2022 Buy 41 414 Ramsay David A Common Stock
Dec 20, 2022 Buy 3 586 Ramsay David A Common Stock
Dec 20, 2022 Buy 13 830 Ramsay David A Common Stock
Dec 19, 2022 Buy 40 719 Ramsay David A Common Stock
Dec 16, 2022 Buy 341 Ramsay David A Common Stock
Dec 13, 2022 Buy 40 000 Sun Ricky Stock Option (Right to Buy)
Dec 13, 2022 Buy 40 000 Mccracken Joseph S Stock Option (Right to Buy)
Dec 13, 2022 Buy 40 000 Van Es-johansson An Stock Option (Right to Buy)
Dec 13, 2022 Buy 40 000 Ramsay David A Stock Option (Right to Buy)
Dec 13, 2022 Buy 40 000 Hawkins Richard J Stock Option (Right to Buy)
Dec 13, 2022 Buy 40 000 Elam Nevan C Stock Option (Right to Buy)
Dec 13, 2022 Buy 1 172 Elam Nevan C Common Stock
Dec 13, 2022 Sell 1 172 Elam Nevan C Stock Option (Right to Buy)
Dec 13, 2022 Buy 325 000 Pauls Matthew Common Stock
Dec 13, 2022 Buy 700 000 Pauls Matthew Stock Option (Right to Buy)
Dec 13, 2022 Buy 250 000 Lowrance David L Stock Option (Right to Buy)
Dec 13, 2022 Buy 100 000 Lowrance David L Common Stock
Dec 07, 2022 Buy 1 172 Hawkins Richard J Common Stock
Dec 07, 2022 Sell 1 172 Hawkins Richard J Stock Option (Right to Buy)
Nov 23, 2022 Buy 4 610 Ramsay David A Common Stock
Nov 22, 2022 Buy 15 495 Ramsay David A Common Stock
Nov 21, 2022 Buy 375 000 Pratt Raymond Dennis Stock Option (Right to Buy)
Nov 21, 2022 Buy 150 000 Pratt Raymond Dennis Common Stock
Nov 21, 2022 Buy 25 005 Ramsay David A Common Stock
Nov 18, 2022 Buy 16 100 Ramsay David A Common Stock
Nov 17, 2022 Buy 8 900 Ramsay David A Common Stock
Nov 10, 2022 Buy 0 Pratt Raymond Dennis
Nov 10, 2022 Buy 0 Pratt Raymond Dennis
Sep 27, 2022 Buy 73 893 Ramsay David A Common Stock
Sep 26, 2022 Buy 31 107 Ramsay David A Common Stock
Sep 23, 2022 Buy 30 000 Ramsay David A Common Stock
Sep 20, 2022 Buy 600 Ramsay David A Common Stock
Sep 19, 2022 Buy 1 400 Ramsay David A Common Stock
Sep 16, 2022 Buy 6 000 Ramsay David A Common Stock
Sep 08, 2022 Buy 29 000 Ramsay David A Common Stock
Sep 07, 2022 Buy 2 130 Ramsay David A Common Stock
Sep 06, 2022 Buy 870 Ramsay David A Common Stock
INSIDER POWER
84.958
Last 100 transactions
Buy: 8 363 114 | Sell: 445 126 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 84.958.

In total, the insiders bought 8 363 114 and sold 445 126 SVRA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Savara Inc

Savara Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.... SVRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT